A novel stop-loss variant in ISG15 causes C-terminal dysfunction and impairs USP18-mediated negative feedback
Wanyu Zhang, Xiongbin Chen, Yulu Li, Xingfeng Yao, Jinyan Huang, Yijiu Gao, Wenlu Xing, Dan Lu, Mengyue Deng, Zhou Shu, Huawei Mao · 2026
Read A novel stop-loss variant in ISG15 causes C-terminal dysfunction and impairs USP18-mediated negative feedback by Wanyu Zhang, Xiongbin Chen, Yulu Li, Xingfeng Yao, Jinyan Huang, Yijiu Gao, Wenlu Xing, Dan Lu, Mengyue Deng, Zhou Shu, Huawei Mao (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13627440.txt.
Description
Wanyu Zhang and co-authors report a 2026 case that adds a new twist to a rare immune disorder. A protein called ISG15 normally helps switch off interferon signals after they fire. When that brake fails, lasting signals can drive fever and inflamed skin.
The team studied a young boy in China with early fever, severe skin ulcers, and raised liver enzymes. Gene tests found new variants at the tail end of ISG15, and cell tests showed the tail change weakens the brake on interferon. A drug that blocks the Janus kinase path was used in care. The case widens what doctors know about this gene.
Catalog record
| CREATOR | Wanyu Zhang, Xiongbin Chen, Yulu Li, Xingfeng Yao, Jinyan Huang, Yijiu Gao, Wenlu Xing, Dan Lu, Mengyue Deng, Zhou Shu, Huawei Mao |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |